PEAK6 Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

PEAK6 Investments’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$197K	–	4748
2023 Q2	$197K	Sell	5,000 -3,223	-39%	-$114K	﹤0.01%	2885
2023 Q1	$200K	Sell	8,223 -2,777	-25%	-$60.8K	﹤0.01%	3110
2022 Q4	$236K	Buy	+11,000	New	+$235K	﹤0.01%	3165
2022 Q3	–	Sell	-5,000	Closed	-$197K	–	5839
2022 Q2	$197K	Buy	+5,000	New	+$62.8K	﹤0.01%	2886

PEAK6 Investments's ISEE Position: Q3 2023 in Review

PEAK6 Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 5,000 shares — an estimated $197K sold.

PEAK6 Investments first reported a position in ISEE in Q2 2022 and held it in 4 quarters. The position peaked at $236K in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

PEAK6 Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
PEAK6 Investments sold 5,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $197K.
PEAK6 Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
PEAK6 Investments's IVERIC bio, Inc. Common Stock position peaked at $236K in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.